Model
Edge
Nabriva Therapeutics
0001693064
Filing Type
4
Filing Date
1/3/2023
Updated
1/4/23, 11:08 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership